Avacta Quarterly Update | 31-Mar-2025 | 07:00 | RNS |
Avacta Announces Presentations at AACR | 26-Mar-2025 | 07:00 | RNS |
Avacta Completes Launch Diagnostics Sale | 25-Mar-2025 | 07:00 | RNS |
Avacta to Present at Leerink Healthcare Conference | 10-Mar-2025 | 07:00 | RNS |
Avacta announces data update for AVA6000 | 07-Mar-2025 | 08:40 | RNS |
Avacta to sell Launch Diagnostics | 07-Mar-2025 | 07:42 | RNS |
Appointment of Joint Broker | 04-Feb-2025 | 07:00 | RNS |
Issue of Equity and Total Voting Rights | 21-Jan-2025 | 15:09 | RNS |
Avacta Announces Data from AVA6000 Phase 1 trial | 16-Jan-2025 | 07:00 | RNS |
Avacta Appoints Chief Financial Officer | 13-Jan-2025 | 07:00 | RNS |
Completion of Dose Escalation and RDE Arms | 12-Dec-2024 | 07:00 | RNS |
R&D Spotlight focusing on pipeline advances | 30-Oct-2024 | 07:00 | RNS |
Block Listing Six Monthly Return | 28-Oct-2024 | 07:00 | RNS |
Avacta Reports Pipeline Avances at EORTC | 24-Oct-2024 | 07:00 | RNS |
Issue of Equity and Total Voting Rights | 21-Oct-2024 | 16:00 | RNS |
Currency | UK Pounds |
Share Price | 33.50p |
Change Today | -2.20p |
% Change | -6.16 % |
52 Week High | 82.50 |
52 Week Low | 33.00 |
Volume | 1,987,916 |
Shares Issued | 376.22m |
Market Cap | £126.03m |
Beta | 0.02 |
RiskGrade | 461 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
16:35 | 66,000 @ 33.50p |
16:35 | 66,000 @ 33.50p |
16:25 | 2,500 @ 34.43p |
16:19 | 35,000 @ 34.35p |
16:19 | 21,341 @ 34.17p |
You are here: research